A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
(1)
,
(2)
,
(3)
,
(4)
,
(5)
,
(6)
,
(7)
,
(8)
,
(9)
,
(10)
,
(11)
,
(12)
,
(13)
,
(14)
,
(15)
,
(16)
,
,
(15)
,
(15, 17)
,
(4)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Nicolas Penel
- Function : Author
- PersonId : 769049
- ORCID : 0000-0001-5243-1548
- IdRef : 061101109
Olivier Mir
- Function : Author
- PersonId : 791180
- ORCID : 0000-0002-6761-4002
- IdRef : 160522498
Isabelle Ray-Coquard
- Function : Author
- PersonId : 760354
- ORCID : 0000-0003-2472-8306
Antoine Italiano
- Function : Author
- PersonId : 760314
- ORCID : 0000-0002-8540-5351
François Bertucci
- Function : Author
- PersonId : 753650
- IdHAL : francois-bertucci
- ORCID : 0000-0002-0157-0959
Lucie Laroche
- Function : Author
Jean-Yves Blay
- Function : Author
- PersonId : 756201
- ORCID : 0000-0001-7190-120X
- IdRef : 069035407